Open AccessLong‐term remission in an aggressive C rooke cell adenoma of the pituitary , 18 months after discontinuation of treatment with temozolomide
Author(s) -
Asimakopoulou Athina,
Tzanela Marinela,
Koletti Ageliki,
Kontogeorgos George,
Tsagarakis Stylianos
Publication year - 2014
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.39
Subject(s) - medicine , discontinuation , temozolomide , complete remission , pituitary adenoma , oncology , pediatrics , adenoma , chemotherapy
Key Clinical Message The clinical course of our patient, who sustained remission status for at least 18 months highlights the chance of long‐term hormonal and tumor remission and demonstrates the efficacy and safety of discontinuation of temozolomide therapy. Prospective studies are required in order to define predictors of long‐term remission of this promising therapeutic modality.